Antibodies that bind to EphA2 and methods of use thereof
US7569672B2 · kind B2 · utility
13Cited by
20References
56Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2006 |
| Grant date | Aug 4, 2009 |
| Priority date | — |
| Expiry date | Jan 3, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/77
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein is disclosure about the development and characterization of an antibody that binds to antigen EphA2 which is present on a variety of human cancers from breast, lung, prostate, and colons. Methods of diagnosing and treating various cancers by using such antibodies directed against this antigen are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.